Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2014, Article ID 478326, 3 pages
http://dx.doi.org/10.1155/2014/478326
Case Report

Fatal Gastrointestinal Hemorrhage in a Young Boy with Newly Diagnosed Metastatic Medulloblastoma on High Dose Dexamethasone

1Division of Hematology Oncology, Department of Pediatrics, University of California-San Diego, 3020 Children’s Way MC5009, San Diego, CA 92123, USA
2Department of Neurosciences, University of California-San Diego, USA

Received 8 September 2014; Revised 28 October 2014; Accepted 28 October 2014; Published 13 November 2014

Academic Editor: Maria Moschovi

Copyright © 2014 Victor Wong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Dietrich, K. Rao, S. Pastorino, and S. Kesari, “Corticosteroids in brain cancer patients: benefits and pitfalls,” Expert Review of Clinical Pharmacology, vol. 4, no. 2, pp. 233–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Koehler, “Use of corticosteroids in neuro-oncology,” Anti-Cancer Drugs, vol. 6, no. 1, pp. 19–33, 1995. View at Google Scholar · View at Scopus
  3. A. Sturdza, B.-A. Millar, N. Bana et al., “The use and toxicity of steroids in the management of patients with brain metastases,” Supportive Care in Cancer, vol. 16, no. 9, pp. 1041–1048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. C. Ryken, M. McDermott, P. D. Robinson et al., “The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline,” Journal of Neuro-Oncology, vol. 96, no. 1, pp. 103–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. G. ReMine and D. C. McIlrath, “Bowel perforation in steroid-treated patients,” Annals of Surgery, vol. 192, no. 4, pp. 581–586, 1980. View at Publisher · View at Google Scholar · View at Scopus
  6. D. E. Weissman, D. Dufer, V. Vogel, and M. D. Abeloff, “Corticosteroid toxicity in neuro-oncology patients,” Journal of Neuro-Oncology, vol. 5, no. 2, pp. 125–128, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Heimdal, H. Hirschberg, H. Slettebo, K. Watne, and O. Nome, “High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression,” Journal of Neuro-Oncology, vol. 12, no. 2, pp. 141–144, 1992. View at Google Scholar · View at Scopus
  8. D. A. Henry, A. Johnston, A. Dobson, and J. Duggan, “Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids,” The British Medical Journal, vol. 295, no. 6608, pp. 1227–1229, 1987. View at Publisher · View at Google Scholar · View at Scopus
  9. G. L. Nielsen, H. T. Sørensen, L. Mellemkjœr et al., “Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study,” The American Journal of Medicine, vol. 111, no. 7, pp. 541–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. C. E. Fadul, W. Lemann, H. T. Thaler, and J. B. Posner, “Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease,” Neurology, vol. 38, no. 3, pp. 348–352, 1988. View at Publisher · View at Google Scholar · View at Scopus
  11. M. McDonnell and N. Evans, “Upper and lower gastrointestinal conaplications with dexamethasone despite H2 antagonists,” Journal of Paediatrics and Child Health, vol. 31, no. 2, pp. 152–154, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. The Vermont Oxford Network Steroid Study Group, “Early postnatal dexamethasone therapy for the prevention of chronic lung disease,” Pediatrics, vol. 108, pp. 741–748, 2001. View at Publisher · View at Google Scholar
  13. J. P. A. Ioannidis, M. D. Samarel, J. Lau, and M. S. Drapkin, “Risk of gastrointestinal bleeding from dexamethasone in children with bacterial meningitis,” The Lancet, vol. 343, no. 8900, p. 792, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. R. P. Dellinger, M. M. Levy, J. M. Carlet et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008,” Intensive Care Medicine, vol. 34, no. 1, pp. 17–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. J. Freij and B. M. Gebara, “Risk of gastrointestinal bleeding from dexamethasone in children with bacterial meningitis,” Lancet, vol. 343, no. 8906, p. 1165, 1994. View at Google Scholar · View at Scopus
  16. L. Recht, L. L. Mechtler, E. T. Wong, P. C. O'Connor, and B. E. Rodda, “Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy,” Journal of Clinical Oncology, vol. 31, no. 9, pp. 1182–1187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Wheeler, J. Black, S. Webb, and H. Shen, “Dehiscence of corticosteroid-induced abdominal striae in a 14-year-old boy treated with bevacizumab for recurrent glioblastoma,” Journal of Child Neurology, vol. 27, no. 7, pp. 927–929, 2012. View at Publisher · View at Google Scholar · View at Scopus